Dual-pathway framing
Considered when a clinician determines a dual-pathway weight-management approach may be appropriate for your history and goals.

Named Menovia Care · U.S. pharmacy partners on prescription
$345/mo
Evaluation included
Concentration
5 mg/mL · 2 mL
Injectable · clinician review · discreet shipping
Rx · Weight care
Tirzepatide is offered on Menovia Care as a dual-pathway weight-management option inside a clinician-gated model: complete intake, receive licensed review, and proceed only when prescribed. Clear pricing. Honor The Pause.
Honor The Pause
Concentration
5 mg/mL · 2 mL
Form
Injectable solution
Your licensed provider sets dose, frequency, and duration after reviewing your goals and history. Never alter a prescribed schedule without clinical guidance.
Public schedules are educational only. Your prescribing clinician sets the exact protocol after intake.
Educational information only. Therapies are provided only after licensed clinician evaluation where legally permitted.
Considered when a clinician determines a dual-pathway weight-management approach may be appropriate for your history and goals.
Ongoing check-ins and adjustments stay with your Menovia Care team beyond the first shipment.
One clear monthly price — $345 — with evaluation included. No surprise consultation line item.
Tirzepatide appears in clinical literature exploring metabolic and weight-management pathways. Research context is educational; clinical use requires licensed clinician judgment. Menovia Care does not promise outcomes.
A U.S.-licensed clinician reviews your intake and decides whether treatment is medically appropriate. Purchasing does not guarantee a prescription.
Explore other treatments
Tirzepatide
$345/mo · eval included